Nixon Peabody Trust Co. Purchases New Position in Abbott Laboratories (NYSE:ABT)

Nixon Peabody Trust Co. purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,157 shares of the healthcare product maker’s stock, valued at approximately $209,000. Several other hedge […]

Related Keywords

Zurich ,Züsz ,Switzerland ,Danielj Starks ,Andreaf Wainer , ,Blackrock Inc ,Exchange Commission ,Abbott Laboratories ,Morgan Stanley ,Capital International Investors ,Capital Research Global Investors ,Jefferies Financial Group ,Bank Julius Baer Co ,Ltd Zurich ,Nixon Peabody Trust Co ,Nixon Peabody Trust ,Free Report ,Julius Baer ,Research Global Investors ,Street Corp ,International Investors ,Director Daniel ,Get Free Report ,Financial Group ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,